Resmed (RSMDF) Amortization of Deferred Charges (2009 - 2021)

Resmed has reported Amortization of Deferred Charges for 4 years, with the latest figure at $8.5 million in Q3 2021.

• For the quarter ending Q3 2021, Amortization of Deferred Charges fell 18.28% year-over-year to $8.5 million; the trailing twelve-month figure through Sep 2021 stood at $32.9 million (up 6.05% YoY), and the FY2021 full-year result was $34.8 million, up 31.06% from the prior year.
• Amortization of Deferred Charges for Q3 2021 stood at $8.5 million, down from $9.0 million in the prior quarter.
• The five-year high for Amortization of Deferred Charges was $10.4 million in Q3 2020, with the low at $6.0 million in Q3 2019.
• Historically, Amortization of Deferred Charges has averaged $7.8 million across 3 years, with a median of $7.5 million in 2020.
• Annual changes were most pronounced in 2020 — Amortization of Deferred Charges surged 74.78% — and 2021, when it slipped 18.28%.
• Resmed's Amortization of Deferred Charges stood at $6.4 million in 2019, then advanced by 17.75% to $7.5 million in 2020, then gained by 13.73% to $8.5 million in 2021.
• The last three Amortization of Deferred Charges figures came in at $8.5 million (Q3 2021), $9.0 million (Q2 2021), and $7.9 million (Q1 2021), per Business Quant data.